Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Antibiotics >  Cephalosporins Drugs >  Unii-p9vxv1408y

Unii-p9vxv1408y

Basic information Safety Supplier Related

Unii-p9vxv1408y Basic information

Product Name:
Unii-p9vxv1408y
Synonyms:
  • Ceftaroline
  • Unii-p9vxv1408y
  • acetic acid,(6R,7R)-7-[[(2Z)-2-ethoxyimino-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl]amino]-3-[[4-(1-methylpyridin-1-ium-4-yl)-1,3-thiazol-2-yl]sulfanyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,hydrate
  • Ceftaroline Fosamil Acetate Hydrate
  • Ceftaroline Impurity8
  • 4-[2-[[(6R
  • 4-thiadiazol-3-yl]acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]thio]-4-thiazolyl]-1-methylpyridinium acetate hydrate
  • 7R)-2-Carboxy-7-[[(2Z)-(ethoxyimino)[5-(phosphonoamino)-1
CAS:
866021-48-9
MW:
0
Product Categories:
  • Amines
  • API
  • Chiral Reagents
  • Heterocycles
Mol File:
Mol File
More
Less

Unii-p9vxv1408y Usage And Synthesis

Definition

ChEBI: Ceftaroline fosamil acetate monohydrate is a hydrate that is the monohydrate form of ceftaroline fosamil acetate. A prodrug for ceftaroline, used for the treatment of adults with acute bacterial skin and skin structure infections. It has a role as an antimicrobial agent, an antibacterial drug and a prodrug. It contains a ceftaroline fosamil acetate.

Antimicrobial activity

A semisynthetic cephalosporin formulated as the water-soluble fosamil acetate prodrug for intravenous administration. Its properties are similar to those of ceftobiprole, with which it shares an enhanced affinity for penicillin-binding protein 2′ (2a) of methicillin-resistant Staph. aureus. It is hydrolyzed by extended-spectrum β-lactamases and is not active against Amp-C derepressed strains of Gram-negative bacilli.

Pharmacokinetics

Cmax 600 mg intravenous (1-h infusion): 19 mg/L end infusion
Plasma half-life: 2.6 h
Volume of distribution: 0.37 L/kg
Plasma protein binding :<20%
Like ceftobiprole, ceftaroline fosamil is rapidly hydrolyzed in plasma after intravenous infusion and excreted principally in urine. In preliminary clinical studies it appears to be well tolerated.

Unii-p9vxv1408ySupplier

Yield Pharmaceutical Techonlogy (Suzhou) Co.,Ltd. Gold
Tel
13382188332
Email
307446954@qq.com
Jinan Guoding Pharmaceutical Technology Co., Ltd. Gold
Tel
13153106106
Email
sales@guodingpharma.com
Hubei Hicks Biochemical Co., Ltd Gold
Tel
17362916295; 17362916295
Email
w17362916295@163.com
Hunan Hui Bai Shi Biotechnology Co., Ltd.
Tel
0731-85526065 13308475853
Email
ivy@hnhbsj.com
ShangHai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847 13636370518
Email
shyysw007@163.com